S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
NASDAQ:SCPH

scPharmaceuticals - SCPH Stock Forecast, Price & News

$8.76
+0.23 (+2.70%)
(As of 03/27/2023 04:00 PM ET)
Add
Compare
Today's Range
$8.36
$9.18
50-Day Range
$5.59
$9.47
52-Week Range
$3.68
$10.38
Volume
337,091 shs
Average Volume
546,227 shs
Market Capitalization
$240.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00

scPharmaceuticals MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
98.5% Upside
$18.00 Price Target
Short Interest
Bearish
17.45% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.90
Upright™ Environmental Score
News Sentiment
0.29mentions of scPharmaceuticals in the last 14 days
Based on 16 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.58) to ($1.32) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.00 out of 5 stars

Medical Sector

398th out of 995 stocks

Pharmaceutical Preparations Industry

181st out of 482 stocks


SCPH stock logo

About scPharmaceuticals (NASDAQ:SCPH) Stock

scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.

Receive SCPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for scPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SCPH Stock News Headlines

"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
What Makes scPharmaceuticals, Inc. (SCPH) a New Buy Stock
See More Headlines
Receive SCPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for scPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SCPH Company Calendar

Last Earnings
3/22/2023
Today
3/27/2023
Next Earnings (Estimated)
5/15/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SCPH
Fax
N/A
Employees
26
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.00
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$13.00
Forecasted Upside/Downside
+111.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-28,030,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.06 per share

Miscellaneous

Free Float
26,145,000
Market Cap
$233.98 million
Optionable
Not Optionable
Beta
0.22

Key Executives

  • John H. Tucker
    President, Chief Executive Officer & Director
  • Rachael Nokes
    Treasurer, Chief Financial & Accounting Officer
  • John Mohr
    Senior VP-Clinical Development & Medical Affairs
  • Mike Hassman
    Senior Vice President-Technical Operations
  • Katherine Taudvin
    Director-IR & Corporate Development













SCPH Stock - Frequently Asked Questions

Should I buy or sell scPharmaceuticals stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for scPharmaceuticals in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SCPH shares.
View SCPH analyst ratings
or view top-rated stocks.

What is scPharmaceuticals' stock price forecast for 2023?

6 brokers have issued twelve-month price targets for scPharmaceuticals' stock. Their SCPH share price forecasts range from $13.00 to $25.00. On average, they predict the company's stock price to reach $18.00 in the next year. This suggests a possible upside of 111.0% from the stock's current price.
View analysts price targets for SCPH
or view top-rated stocks among Wall Street analysts.

How have SCPH shares performed in 2023?

scPharmaceuticals' stock was trading at $7.17 on January 1st, 2023. Since then, SCPH shares have increased by 19.0% and is now trading at $8.53.
View the best growth stocks for 2023 here
.

When is scPharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 15th 2023.
View our SCPH earnings forecast
.

How were scPharmaceuticals' earnings last quarter?

scPharmaceuticals Inc. (NASDAQ:SCPH) announced its earnings results on Wednesday, March, 22nd. The company reported ($0.30) earnings per share for the quarter, topping analysts' consensus estimates of ($0.42) by $0.12.

What ETFs hold scPharmaceuticals' stock?

ETFs with the largest weight of scPharmaceuticals (NASDAQ:SCPH) stock in their portfolio include AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC).

What other stocks do shareholders of scPharmaceuticals own?
When did scPharmaceuticals IPO?

(SCPH) raised $96 million in an initial public offering on Friday, November 17th 2017. The company issued 6,400,000 shares at $14.00-$16.00 per share. Jefferies, Leerink Partners and BMO Capital Markets acted as the underwriters for the IPO.

What is scPharmaceuticals' stock symbol?

scPharmaceuticals trades on the NASDAQ under the ticker symbol "SCPH."

Who are scPharmaceuticals' major shareholders?

scPharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional shareholders include AIGH Capital Management LLC (9.30%), Armistice Capital LLC (7.83%), RA Capital Management L.P. (6.77%), Millennium Management LLC (3.01%), Dimensional Fund Advisors LP (0.78%) and Renaissance Technologies LLC (0.77%). Insiders that own company stock include 5Am Partners Iv, Llc, Andrew J Schwab, Jack A Khattar, John H Tucker and Orbimed Advisors Llc.
View institutional ownership trends
.

How do I buy shares of scPharmaceuticals?

Shares of SCPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is scPharmaceuticals' stock price today?

One share of SCPH stock can currently be purchased for approximately $8.53.

How much money does scPharmaceuticals make?

scPharmaceuticals (NASDAQ:SCPH) has a market capitalization of $233.98 million. The company earns $-28,030,000.00 in net income (profit) each year or ($1.30) on an earnings per share basis.

How can I contact scPharmaceuticals?

scPharmaceuticals' mailing address is 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA, 01830. The official website for the company is www.scpharma.com. The company can be reached via phone at (617) 517-0730 or via email at tignelzi@scpharma.com.

This page (NASDAQ:SCPH) was last updated on 3/27/2023 by MarketBeat.com Staff